Evidence map›Paper›PMID 25713383›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Differential fates of biomolecules delivered to target cells via extracellular vesicles.

Masamitsu Kanada, Michael H Bachmann, Jonathan W Hardy, Daniel Omar Frimannson, Laura Bronsart, Andrew Wang, Matthew D Sylvester, Tobi L Schmidt, Roger L Kaspar, Manish J Butte and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 270 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
270citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

270 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

210 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Masamitsu KanadaDepartments of Pediatrics.
Michael H BachmannDepartments of Pediatrics.
Jonathan W HardyDepartments of Pediatrics.
Daniel Omar FrimannsonMicrobiology and Immunology, and.
Laura BronsartDepartments of Pediatrics.
Andrew WangDepartments of Pediatrics.
Matthew D SylvesterMicrobiology and Immunology, and.
Tobi L SchmidtDepartments of Pediatrics.
Roger L KasparTransDerm Inc., Santa Cruz, CA 95060.
Manish J ButteDepartments of Pediatrics.ORCID http://orcid.org/0000-0002-4490-5595
A C MatinMicrobiology and Immunology, and.
Christopher H ContagDepartments of Pediatrics, Microbiology and Immunology, and Radiology, Stanford University School of Medicine, Stanford, CA 94305; and ccontag@stanford.edu.

Funding

HER2-targeted exosomal delivery of therapeutic mRNA for enzyme pro-drug therapyUH3TR000902 · NCATS · STANFORD UNIVERSITY · PI MATIN, AC · 2016 to 2017
$2.0M
HER2-targeted exosomal delivery of therapeutic mRNA for enzyme pro-drug therapyUH2TR000902 · NCATS · STANFORD UNIVERSITY · PI MATIN, AC · 2013 to 2015
$1.6M
Influences of nanomechanical forces on T cellsR01GM110482 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BUTTE, MANISH J · 2014 to 2018
$1.6M
NCATS NIH HHS 1UH2TR000902-01NCATS NIH HHS UH2 TR000902NCATS NIH HHS UH3 TR000902NIGMS NIH HHS R01 GM110482
6 · The paper itself

Abstract

Extracellular vesicles (EVs), specifically exosomes and microvesicles (MVs), are presumed to play key roles in cell-cell communication via transfer of biomolecules between cells. The biogenesis of these two types of EVs differs as they originate from either the endosomal (exosomes) or plasma (MVs) membranes. To elucidate the primary means through which EVs mediate intercellular communication, we characterized their ability to encapsulate and deliver different types of macromolecules from transiently transfected cells. Both EV types encapsulated reporter proteins and mRNA but only MVs transferred the reporter function to recipient cells. De novo reporter protein expression in recipient cells resulted only from plasmid DNA (pDNA) after delivery via MVs. Reporter mRNA was delivered to recipient cells by both EV types, but was rapidly degraded without being translated. MVs also mediated delivery of functional pDNA encoding Cre recombinase in vivo to tissues in transgenic Cre-lox reporter mice. Within the parameters of this study, MVs delivered functional pDNA, but not RNA, whereas exosomes from the same source did not deliver functional nucleic acids. These results have significant implications for understanding the role of EVs in cellular communication and for development of EVs as delivery tools. Moreover, studies using EVs from transiently transfected cells may be confounded by a predominance of pDNA transfer.

Indexed as

AnimalsApoptosisBiological TransportCell CommunicationCell MembraneDNAExosomesFlow CytometryGene SilencingGenes, ReporterHEK293 CellsHumansIntegrasesLipidsMacromolecular SubstancesMiceCre recombinaseDNAIntegrasesLipidsMacromolecular SubstancesPhosphatidylserinesPolyethylene GlycolsRNA, MessengerTetraspanin 30apoptotic bodycell communicationexosomeextracellular vesiclemicrovesicle

Identifiers

PMID25713383
PMCPMC4378439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.